Unlock instant, AI-driven research and patent intelligence for your innovation.

γδ-T cell exosomes for tumor immunotherapy and preparation method thereof

An immunotherapy and exosome technology, which is applied in the field of tumor treatment, can solve the problems of limited curative effect and achieve the effects of avoiding diffusion difficulties, inhibiting tumor growth, and enhancing anti-tumor immunity

Active Publication Date: 2020-12-22
SICHUAN CANCER HOSPITAL
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, more studies are using DC-derived exosomes to carry tumor-specific antigens for anti-tumor therapy, but phase I clinical trials have shown very limited efficacy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • γδ-T cell exosomes for tumor immunotherapy and preparation method thereof
  • γδ-T cell exosomes for tumor immunotherapy and preparation method thereof
  • γδ-T cell exosomes for tumor immunotherapy and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] A kind of γδT cell exosomes for tumor immunotherapy, the γδT cell exosomes are loaded with miR-138.

[0039] The expression level of miR-138 is 500 copy / ul.

Embodiment 2

[0041] A kind of γδT cell exosomes for tumor immunotherapy, the γδT cell exosomes are loaded with miR-138.

[0042] The expression level of miR-138 is 1000 copy / ul.

Embodiment 3

[0044] A kind of γδT cell exosomes for tumor immunotherapy, the γδT cell exosomes are loaded with miR-138.

[0045] The expression level of miR-138 is 2000 copy / ul.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a γδT cell exosome for tumor immunotherapy, and the γδT cell exosome is loaded with miR-138. Using γδT cell-derived exosomes (γδTDE) carrying exogenous miR-138 to directly target and kill tumor cells, while inhibiting PD-1 / PD-L1 to enhance the anti-tumor immune activity of T lymphocytes / NK cells, through direct And indirect ways to achieve the effect of inhibiting tumor growth / invasion / metastasis.

Description

technical field [0001] The invention belongs to the technical field of tumor treatment, and in particular relates to a γδT cell exosome used for tumor immunotherapy. Background technique [0002] Tumor immunotherapy has received great attention recently, and was rated as the top ten scientific and technological breakthroughs of the year by Science in 2013, and has broad application prospects. Despite promising results in the treatment of hematological malignancies and malignant melanoma, immunotherapy has had little effect in most solid tumors. [0003] T lymphocytes are the final effector cells of anti-tumor immunity. Adoptive Cell Therapy (ACT), which reinfuses T lymphocytes activated by tumor-associated antigens (TAAs) to treat tumors, has received extensive attention in recent years. . In particular, chimeric antigen receptor (CAR)-modified T cell (CAR-T) technology has achieved rapid development and has shown strong efficacy in the treatment of hematological malignanc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/10C12N15/867A61K31/7088A61K47/46A61K35/17A61P35/00
CPCA61K31/7088A61K35/17A61K47/46C12N5/0636C12N15/86C12N2510/00C12N2740/15043C12N2800/107A61K2300/00
Inventor 朱桂全曹邦荣
Owner SICHUAN CANCER HOSPITAL